In a positive development, the Government yesterday (26 June) informed the Supreme Court that Ahmedabad-based Zydus Cadila's new COVID-19 vaccine will soon be available for those in the age group of 12-18 years, Livemint.
The Government also told the court that while Covishield, Covaxin and Sputnik V are being used to inoculate the population presently, more domestic vaccines such as those from Zydus Cadila and Hyderabad-based biological E are in the late stages of clinical trials and subject to regulatory approvals, will further increase the availability of vaccines.
The government also informed the top court that the production capacity of COVID-19 vaccines in the country is being ramped up and that the supply is expected to further increase in the next few months.
The Government also said, "As per the projected midyear population for 2020, the total population of the country aged 18 years and above is approximately 93-94 crore and as such, administering two doses to these beneficiaries would require an estimated 186 to 188 crore vaccine doses."
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.